Houlihan Lokey Advises Carolina Components

Houlihan Lokey is pleased to announce that Carolina Components Group (CCG) has been acquired by Sheridan Capital Partners (Sheridan).

Founded in 2020 and headquartered in Durham, North Carolina, CCG supplies ultra-pure components, custom-engineered single-use assemblies, and process solutions that support highly regulated biopharmaceutical production environments for more than 250 biopharmaceutical and contract manufacturing customers. As a customer service-focused partner, CCG leverages its extensive experience and bioprocessing expertise to address growing industry demand and new technology requirements.

Sheridan is a private equity firm focused exclusively on partnering with businesses across the healthcare landscape, including outsourced services, products and manufacturing, providers, and software and technology. Sheridan’s engaged operational approach brings strategic resources and deep industry expertise with the purpose of accelerating growth, building enduring value, and generating strong results.

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership in the medical technology and life science tools and services sectors. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2025, the group closed 35 transactions in the U.S. and was ranked by LSEG as the No. 1 advisor for all global healthcare M&A transactions.*

Financial terms of the transaction were not disclosed.

Houlihan Lokey served as the exclusive financial advisor to CCG.

*Excludes accounting firms and brokers.

RELATED: Medical Technology, Mergers and Acquisitions